Last reviewed · How we verify
Identification of biological markers
Identification of biological markers is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development.
At a glance
| Generic name | Identification of biological markers |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Clonal Evolution in Follicular Lymphoma
- A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (NA)
- Hematological Markers in Idiopathic Carpal Tunnel Syndrome
- Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption (NA)
- Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy (NA)
- CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction
- Identification of Biomarkers in Cervical Mucus (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Identification of biological markers CI brief — competitive landscape report
- Identification of biological markers updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Identification of biological markers
What is Identification of biological markers?
Identification of biological markers is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris.
Who makes Identification of biological markers?
Identification of biological markers is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).
What development phase is Identification of biological markers in?
Identification of biological markers is in Phase 2.